115 related articles for article (PubMed ID: 7198453)
1. Pharmacokinetics of cefapirin in patients with normal and impaired renal functions.
Bergan T; Orjavik O; Brodwall EK
Arzneimittelforschung; 1981; 31(10):1773-6. PubMed ID: 7198453
[TBL] [Abstract][Full Text] [Related]
2. Kidney transport of cefapirin in normal and impaired renal function.
Brodwall EK; Orjavik O; Bergan T
Arzneimittelforschung; 1981; 31(12):2157-9. PubMed ID: 7199318
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of ceftazidime in normal and impaired renal function.
Höffler D; Koeppe P; Williams KJ
Arzneimittelforschung; 1984; 34(1):72-6. PubMed ID: 6367755
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology of cefamandole in patients with reduced renal function.
Czerwinski AW; Pederson JA
Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and serum concentrations of cephapirin in neonatal foals.
Brown MP; Gronwall R; Gossman TB; Houston AE
Am J Vet Res; 1987 May; 48(5):805-6. PubMed ID: 3592380
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of sulfaclomide and sulfamerazine in patients with impaired renal function after first and after repeated application.
Traeger A; Stein G
Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):315-20. PubMed ID: 892948
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of nimodipine in normal and impaired renal function.
Kirch W; Rämsch KD; Dührsen U; Ohnhaus EE
Int J Clin Pharmacol Res; 1984; 4(5):381-4. PubMed ID: 6519852
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and body fluid and endometrial concentrations of cephapirin in mares.
Brown MP; Gronwall RR; Houston AE
Am J Vet Res; 1986 Apr; 47(4):784-8. PubMed ID: 3963579
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
Höffler D; Koeppe P
Arzneimittelforschung; 1983; 33(2):269-72. PubMed ID: 6303362
[TBL] [Abstract][Full Text] [Related]
10. [Cefamandol: pharmacokinetics with normal and impaired renal function (author's transl)].
Höffler D; Moecke D; Sassmann M
Dtsch Med Wochenschr; 1978 Aug; 103(34):1334-8. PubMed ID: 679835
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the new broad spectrum penicillin CP-33994-2.
Bergan T; Brodwall EK; Orjavik O
Arzneimittelforschung; 1980; 30(7):1144-7. PubMed ID: 7191297
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
[TBL] [Abstract][Full Text] [Related]
14. Pleural fluid levels of cefoxitin in patients with renal impairment.
Barrueco M; Otero MJ; Garcia MJ; Lanao JM; Dominguez-Gil A
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):485-9. PubMed ID: 3781682
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of cephapirin sodium in plasma and gynecologic tissue after a single preoperative dose.
Fry W; Ximenes J; Siskin SB
Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):92-6. PubMed ID: 7372381
[TBL] [Abstract][Full Text] [Related]
16. Renal excretion of cephapirin and cephaloridine: evidence for saturable tubular reabsorption.
Arvidsson A; Borgå O; Alván G
Clin Pharmacol Ther; 1979 Jun; 25(6):870-6. PubMed ID: 445952
[TBL] [Abstract][Full Text] [Related]
17. Serum half-lives and elimination rates of a new semi-synthetic cephalosporin, cephacetrile, in nephrectomized patients and in patients with impaired or normal renal function.
Reutter F; Maurice NP
Arzneimittelforschung; 1974 Sep; 24(9b):1466-8. PubMed ID: 4479804
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of five cephalosporins in healthy male volunteers.
Paradelis AG; Stathopoulos G; Trianthaphyllidis C; Logaras G
Arzneimittelforschung; 1977; 27(11):2167-70. PubMed ID: 580023
[TBL] [Abstract][Full Text] [Related]
19. The influence of renal function on the elimination kinetics of sulbenicillin in man.
Montanari A; Borghi L; Canali M; Coruzzi P; Novarini A; Borghetti A
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):225-8. PubMed ID: 7390672
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
Welink J; Boven E; Vermorken JB; Gall HE; van der Vijgh WJ
Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
